Aradhana Sarin
Aradhana Sarin is on the board of OraSure Technologies, Inc. and President & Director at Alexion Pharmaceuticals, Inc.
In the past Dr. Sarin occupied the position of MD-Healthcare Corporate & Investment Banking at Citizens, Inc. (Austin, Texas) and Managing Director-Healthcare Investment Banking at UBS AG.
Aradhana Sarin received an MBA from Stanford Graduate School of Business.
Transactions
Date
Transaction
Value
| 12/16/2020 | 2,510 | Derivative/Non-derivative trans. at $157.96 per share. | 396,480 |
| 12/16/2020 | 6,853 | Derivative/Non-derivative trans. at $157.96 per share. | 1,082,500 |
| 12/16/2020 | 15,371 | Award at $0 per share. | 0 |
| 11/30/2020 | 1,298 | Derivative/Non-derivative trans. at $124 per share. | 160,952 |
| 03/02/2020 | 883 | Derivative/Non-derivative trans. at $90.54 per share. | 79,947 |
| 02/28/2020 | 10,880 | Award at $0 per share. | 0 |
| 12/02/2019 | 5,441 | Derivative/Non-derivative trans. at $113.2 per share. | 615,922 |
| 06/21/2019 | 578 | Disposition at $132 per share. | 76,296 |
| 02/28/2019 | 8,250 | Award at $0 per share. | 0 |
| 02/28/2019 | 267 | Derivative/Non-derivative trans. at $132.92 per share. | 35,490 |
